Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01695941
Brief Title: Alisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin Lymphoma

First Submitted : September 26, 2012
First Submitted that Met QC Criteria : September 26, 2012
First Posted : September 28, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : August 12, 2019
Last Update Posted : August 13, 2019